LMGHF yields 95.24% · PFE yields 6.13%● Live data
📍 LMGHF pulled ahead of the other in Year 1
Combined, LMGHF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of LMGHF + PFE for your $10,000?
LINK Mobility Group Holding ASA provides mobile and communication-platform-as-a-service solutions. It operates through five segments: Northern Europe, Western Europe, Central Europe, Northern America, and Global Messaging. The company offers LINK Messaging Gateway that integrates SMS gateway solutions with existing IT and computer systems; LINK Web Experience for creating personalized content with landing pages; LINK Conversations for communication with customer-centric channels, content, and messages; LINK Mobile Invoice, which provides various payment channels in one integrated payment interface; Xenioo Conversational Platform, an omnichannel conversational platform to interact with customers; and LINK Insight Dashboard that offers real-time monitoring of campaign. Its solutions are used in healthcare, retail, finance, and logistics industries. The company was founded in 2001 and is headquartered in Oslo, Norway.
Full LMGHF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.